Find a company
Avatr is anai platform that lets doctors input care and medication plans and removes complexity making it easy for patients to follow. With Avatr, doctors can assess effectiveness of medication against each individual patient’s lifestyles, biomarkers and effects on mental health in order to intervene / intercept when needed, to offer more proactive care at scale. Patients now have the peace of mind that they are being looked after between their visits to the doctor.
| Project | Post-Operative 60 Days |
|---|---|
| Description |
Avatr is an AI platform that lets doctors input care and medication plans and removes complexity making it easy for patients to follow. During the PoP-60 study, the clinical and economic benefits of Avatr will be evaluated for cardiac patients discharged from hospital. |
| Funding | £ 180,564 |
| Competition | Competition 21 - Phase 3, Real-world Implementation: Respiratory Diseases and Cardiovascular Diseases |
| Competition Date | June 2022 |
| Categories | Cardiovascular |
| Health Innovation Network Partner | Imperial College Health Partners |
| Website | https://www.avatr.ai |